Month: June 2021

TORONTO, June 24, 2021 (GLOBE NEWSWIRE) — Angus Gold Inc. (TSX-V: GUS | OTC: ANGVF) (“Angus” or the “Company”) is pleased to announce that Mr. David Cobbold will be joining the Company’s Board of Directors effective June 30, 2021. Mr. Cobbold is a veteran mining investment banker with 23 years of financial services experience. Currently, he is a Managing Director and Head of Mining at Macquarie Capital Markets Canada where he is responsible for sourcing and leading merger, acquisition, sale and defense transactions for clients ranging from exploration and development companies to global metals & mining companies. David’s clients are based in Canada, US, U.K, South African and Australia. In addition, David has extensive experience in global commodity and securities markets. Prior to joining Macquarie, David worked at CIBC World...

Completed an initial public offering with net proceeds, including the exercise of the underwriters’ option in full, of approximately $48.4 million in May 2021 – – –Expanded the management team to support initiation of atacicept clinical development program– – –Initiated Phase 2b ORIGIN clinical trial of atacicept in patients with IgA nephropathy (IgAN) SOUTH SAN FRANCISCO, Calif., June 24, 2021 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today reported its financial results for the first quarter ended March 31, 2021, and provided a corporate update. “Over the past nine months, we completed two capital raises for a total of...

• VSBLTY announces a partnership with RapidSOS and is now recognized as RapidSOS Ready• Through this partnership, VSBLTY sends life-saving emergency data directly to 911 through the RapidSOS Platform in an emergencyPhiladelphia, PA, June 24, 2021 (GLOBE NEWSWIRE) — VSBLTY Group Technologies Corp. (CSE: VSBY) (Frankfurt 5VS) (OTC: VSBGF) (“VSBLTY”), a leading provider of security and analytics technology, and RapidSOS announced today a partnership to provide first responders and 911 telecommunicators with the ability to access incident data from its industry-leading Vector™ software through RapidSOS. Built in partnership with public safety, RapidSOS’s emergency response data platform securely links life-saving data from over 350M connected devices directly to over 4,800 Emergency Communications Centers...

EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (Nasdaq: MIRO) (“Miromatrix”), a life sciences company pioneering a novel technology for bioengineering fully transplantable human organs to help save and improve patients’ lives, today announced the pricing of its initial public offering of 4,800,000 shares of common stock at a price to the public of $9.00 per share. In addition, Miromatrix has granted the underwriter a 30-day option to purchase up to an additional 720,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. The common stock is expected to begin trading on The Nasdaq Capital Market under the ticker symbol “MIRO” on June 24, 2021, and the offering is expected to close on June 28, 2021, subject to the satisfaction...

Primary endpoint, change in DUX4-driven gene expression which was included as an experimental biomarker, was not met Losmapimod showed statistically significant* (p

CALGARY, Alberta, June 24, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT,) (OTCQB: SBUDF) (“Sugarbud” or the “Company”) is pleased to announce the expansion of the Company’s product portfolio in Ontario with the launch of Mule Fuel. Mule Fuel is a very unique high-potency, high-terpene phenotype with a total THC range between 18-24% and terpene profiles between 3-5%. Learn More About The Sugarbud Craft Cannabis Collection Here “We are delighted to be expanding our Craft Cannabis Collection in the Province of Ontario – Canada’s largest and fastest growing recreational cannabis market,” stated Sugarbud’s CEO, John Kondrosky. “In addition to providing Ontario consumers with the potency profiles they are asking for, Mule Fuel is yet...

BOSTON, June 24, 2021 (GLOBE NEWSWIRE) — Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, announced today that it is set to join the Russell Microcap® Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the U.S. market opens on June 28, 2021. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell indexes primarily by objective, market-capitalization rankings and style attributes. “Protection against chemotherapy-induced toxicities represents a significant, largely unaddressed need in the oncology space, and one for which there is...

CHICAGO, June 24, 2021 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that Aaron Miles, the Company’s Chief Investment Officer, will present at VirtualInvestorConferences.com, the leading investor conference series for publicly-traded companies on Tuesday, June 29. DATE: Tuesday, June 29TIME: 10:00 AM ETLINK TO WATCH: https://bit.ly/34Tj6je This will be a live, interactive online event for individual and institutional investors, as well as advisors and analysts. If attendees are unable to join the event live, an archived webcast will also be made available after the event. To learn more about the event, please visit www.virtualinvestorconferences.com. About Virtual Investor Conferences® Virtual Investor Conferences (VIC) is...

CAMBRIDGE, Mass., June 24, 2021 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc., an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, today announced that it will be added to the Russell 2000® Index at the conclusion of the Russell US Indexes annual reconstitution on June 28, 2021. “Werewolf’s inclusion in the Russell 2000® index marks an important milestone that reflects the continued progress we are making toward advancing our lead therapeutic programs, WTX-124 and WTX-330, into the clinic,” said Daniel J. Hicklin, Ph.D., President and Chief Executive Officer of Werewolf Therapeutics. “We are pleased to join the Russell Index and look forward to sharing our story with a broader audience of investors.” The...